- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04799145
Basic Mobility and Balance Performance of Low Active Transfemoral Prosthesis Users With a Powered Prosthetic Knee
Basic Mobility and Balance Performance of Low Active Transfemoral Prosthesis Users With Mobili Knee (a Powered Microprocessor-controlled Knee Prosthesis)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants were consented, and all tests were conducted at the Össur Motion lab Grjótháls 1-5, 110 Reykjavik.
There were two scheduled study events. At the initial visit, the first study event, for each subject a researcher qualified to obtain informed consent seated the subject and proceeded as described in chapter 13.7 Informed consent in [2].
Prior to fitting the subject was asked to provide feedback on their prescribed prosthesis, by filling in a questionnaire and perform AMPro, LCI (modified), TUG test, 2MWT and other validation activities (stand to sit, sit to stand, level ground, stair and ramp walking), as applicable. The users were fitted within the standard methods of prosthetic fitting, alignment, introduction, training and walking on various terrain.
After initial fitting subjects carried out validation tasks (stand to sit, sit to stand tasks, level ground walking at different speeds, stair and ramp walking), stroop test (cognitive loading) and FSST on the investigational device, after which they answered an in-house questionnaire to provide feedback.
During the second event, subjects were fitted with the investigational device and asked to perform the TUG, 2MWT and any validation tasks that could not be completed at visit 1 on the investigational device due to time restraints or subject condition.
If for some reason all tasks could not be completed at visit 1 and 2 due to time restraints or subject condition, a third visit was added.
Subjects did not wear the device home between visits.
Statistical Considerations:
Outcomes were inspected for normality. If the data was deemed to have a normal distribution the hypothesis was tested using a two-tailed, paired t-test (Only hypothesis A and B). If data was deemed non-normal that hypothesis was tested using a Wilcoxon signed rank test. Significance level (alpha) will be set at 0.05.
Other endpoints and acceptance criteria were assessed with descriptive statistics only.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 50Kg< body weight < 116Kg
- Cognitive ability to understand all instructions and questionnaires in the study;
- K1-K2 unilateral transfemoral amputees
- Allows for 37mm knee center height to dome of pyramid alignment
- Age ≥ 18 years
- Willing and able to participate in the study and follow the protocol
- Comfortable and stable socket fit (5 or over on the SFCS)
Exclusion Criteria:
- Users with cognitive impairment
- Users aged <18y
- Bilateral amputees
- Users with stump pain affecting their functional mobility
- Users with socket problems
- Users with co-morbidities in the contra-lateral limb, which significantly affect their functional mobility
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Investigational device
All subjects performed outcome measures on their prescribed knee and the investigational device for comparison.
|
Motorized microprocessor controlled prosthetic knee.
Passive microprocessor controlled knee and mechanical knee
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed Up and Go Test (TUG Test)
Time Frame: 1 week
|
Subjects are timed while completing a task of getting up from a chair, walking 3 meters at self-selected walking speed, turning around a cone and returning to sit down in the chair.Time is stopped from leaving the chair until the subject is sitting again.
The time is measured in seconds.
The faster the subject can complete the task the better.
Results correlate with gait speed, balance, functional level, the ability to go out, and can follow change over time.
It is assumed that subjects that take longer than 14s to complete the TUG might have a higher risk for falls.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
2 Minute Walk Test
Time Frame: 1 week
|
Subjects walk at self-selected walking speed for 2 minutes, they shall walk as far as possible
|
1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CII2020111613
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amputation
-
Shirley Ryan AbilityLabUniversity of AlbertaActive, not recruitingAmputation | Amputation; Traumatic, Hand | Amputation, Traumatic | Amputation; Traumatic, LimbUnited States
-
Liberating Technologies, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAmputation | Prosthesis User | Amputation; Traumatic, Hand | Amputation, CongenitalUnited States
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAmputation | Amputation; Traumatic, Limb | Upper Limb Amputation at the Hand | Upper Limb Amputation at the WristUnited States
-
Medipol UniversityRecruitingEvaluation of Functionality of Amputees According to the Medicare Functional K Classification SystemAmputation | Amputation; Traumatic, Leg, LowerTurkey
-
Point DesignsEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingAmputation; Traumatic, Hand | Amputation, CongenitalUnited States
-
Shirley Ryan AbilityLabRecruitingAmputation | Amputation, Traumatic | Amputation; Traumatic, Limb | Amputation of KneeUnited States
-
Fondazione Don Carlo Gnocchi OnlusCompletedAmputation | Amputation; Traumatic, Leg, LowerItaly
-
Fondazione Don Carlo Gnocchi OnlusCompletedAmputation | Amputation; Traumatic, Leg, LowerItaly
-
Hacettepe UniversityCompleted
-
Liberating Technologies, Inc.Vivonics, Inc.CompletedLower Limb Amputation Below Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation StumpUnited States
Clinical Trials on Investigational device
-
Coloplast A/SCompleted
-
Perrigo CSCIRecruiting
-
NanoVationCompletedChronic Obstructive Pulmonary Disease (COPD)Israel
-
CLASSYS Inc.Not yet recruitingAcne Scars | Acne Scarring | Acne Scar | Acne Scars - AtrophicChina
-
Cutera Inc.CompletedPigmented Skin Lesion of Suspected Benign NatureUnited States
-
Jacobs instituteUniversity at BuffaloCompletedIschemic StrokeUnited States
-
Noctrix Health, Inc.Active, not recruitingRestless Legs SyndromeUnited States
-
Perimeter Medical ImagingCancer Prevention Research Institute of TexasCompletedBreast Cancer FemaleUnited States
-
Kansas City Heart Rhythm Research FoundationNot yet recruitingAtrial Fibrillation
-
Boston Scientific CorporationCompleted